XML 43 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 27, 2014
Schedule of assumptions used to determine fair value of stock options

 

 

 

 

Thirteen Weeks Ended

 

Thirty-Nine Weeks Ended

 

 

 

December 27,
2014

 

December 28,
2013

 

December 27,
2014

 

December 28,
2013

 

 

 

 

 

 

 

 

 

 

 

Expected option term(1)

 

6.5 years

 

6.5 years

 

6.5 years

 

6.5 years

 

Expected volatility factor(2)

 

38.6% - 55.0%

 

56.0% 

 

38.6% - 56.0%

 

56.0% 

 

Risk-free interest rate(3)

 

1.7% - 1.8%

 

1.9% 

 

1.7% - 2.0%

 

1.9% - 2.0%

 

Expected annual dividend yield(4)

 

0% 

 

0% 

 

0% 

 

0% 

 

 

 

(1)

The Company has limited historical information regarding expected option term. Accordingly, the Company determined the expected life of the options using the simplified method.

(2)

Stock volatility for each grant is measured using the weighted average of historical daily price changes of the Company’s competitors’ common stock over the most recent period equal to the expected option term of the Company’s awards.

(3)

The risk-free interest rate is determined using the rate on treasury securities with the same term.

(4)

The board of directors paid a dividend to stockholders in April 2014. The Company’s board of directors does not plan to pay cash dividends in the foreseeable future. Consequently, the Company used an expected dividend yield of zero.

 

 

Schedule of stock award activity

 

The following table summarizes the stock award activity for the thirty-nine weeks ended December 27, 2014 (aggregate intrinsic value in thousands):

 

 

 

 

 

Grant Date

 

Weighted

 

 

 

 

 

 

 

Weighted-

 

Average

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

 

Stock

 

Exercise

 

Contractual

 

Intrinsic

 

 

 

Options

 

Price(1)

 

Life (in Years)

 

Value

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 29, 2014

 

2,515,000 

 

$

5.97 

 

 

 

 

 

Granted

 

362,150 

 

$

12.21 

 

 

 

 

 

Cancelled, forfetied or expired

 

 

$

 

 

 

 

 

Outstanding at December 27, 2014

 

2,877,150 

 

$

6.76 

 

7.7 

 

$

33,556 

 

Vested and expected to vest at December 27, 2014

 

2,877,150 

 

$

6.76 

 

7.7 

 

$

33,556 

 

Exerciseable at December 27, 2014

 

962,850 

 

$

6.61 

 

7.4 

 

$

11,372 

 

 

 

(1)

The grant date weighted-average exercise price reflects the reduction of the exercise price by $2.00 per share for the 1,918,550 unvested options that were part of the April 2014 dividend discussed above.

 

 

Schedule of non-vested stock options

 

 

 

 

 

Weighted-

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

Shares

 

Fair Value

 

 

 

 

 

 

 

Nonvested at March 29, 2014

 

1,793,550

 

$

3.55

 

Granted

 

362,150

 

$

6.55

 

Vested

 

(241,400

)

$

4.63

 

Nonvested shares forfeited

 

 

$

 

Nonvested at December 27, 2014

 

1,914,300

 

$

3.98

 

 

 

CEO  
Schedule of assumptions used to determine fair value of stock options

 

The following significant assumptions were used as of October 29, 2014:

 

Stock price

 

$

16.00 

 

Exercise price

 

$

16.00 

 

Expected option term

 

6.0 years

 

Expected volatility

 

55.0 

%

Risk-free interest rate

 

1.8 

%

Expected annual dividend yield

 

%